Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center unites innovative research and compassionate care to prevent and eliminate cancer and infectious disease. We’re driven by the urgency of our patients, the hope of our community, and our passion for discovery to pursue scientific breakthroughs and healthier lives for every person in every community.
In addition to bringing Seattle Cancer Care Alliance and Fred Hutch together as a single organization, we’ve strengthened our relationship with UW Medicine. While Fred Hutch is an independent, nonprofit organization, it will now also serve as the cancer program for UW Medicine. This unique relationship allows for enhanced care coordination with one of the world's leading integrated health systems.
Subscribe to Fred Hutch’s Oncology Insights e-newsletter to gain clinical and research insights from renowned experts.
Fred Hutchinson Cancer Center
Blinatumomab for Ph- ALL in First MRD-Negative Remission: E1910 and Beyond
- 1 view
- April 29, 2024
Fred Hutchinson Cancer Center
FDA Approval of Liso-Cel in R/R CLL: What You Need to Know
- 48 views
- March 26, 2024
Insights from 2023 ASH Annual Meeting
Clinically-Relevant Updates in ALL in Adults From ASH 2023
- 47 views
- February 20, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Impact of Ibrutinib Dose Reduction on Duration of Therapy in Patients With CLL/SLL"
- 124 views
- December 19, 2023
Fred Hutchinson Cancer Center
MRD Positivity in ALL: Next Steps in Clinical Approach
- 249 views
- May 5, 2023
- 1
Fred Hutchinson Cancer Center
Surveying Safety and Efficacy Data in R/R CLL: ALPINE and ELEVATE-RR Trials
- 515 views
- March 23, 2023
- 2